Safety and Effectiveness of Longer-Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort.
Kristina H LewisHeidi FischerJamy D ArdLee BartonDaniel H BessesenMatthew F DaleyJay DesaiStephanie L FitzpatrickMichael HorbergCorinna KoebnickCaryn OshiroAyae YamamotoDeborah R YoungDavid E ArterburnPublished in: Obesity (Silver Spring, Md.) (2020)
Greater weight loss without increased risk of incident CVD or death was observed in patients using phentermine monotherapy for longer than 3 months. Despite the limitations of the observational design, this study supports the effectiveness and safety of longer-term phentermine use for low-risk individuals.
Keyphrases
- electronic health record
- weight loss
- end stage renal disease
- preterm infants
- ejection fraction
- newly diagnosed
- randomized controlled trial
- bariatric surgery
- cardiovascular disease
- chronic kidney disease
- systematic review
- gestational age
- prognostic factors
- type diabetes
- clinical decision support
- clinical trial
- combination therapy
- patient reported outcomes
- open label
- adverse drug
- skeletal muscle
- study protocol
- glycemic control
- double blind